Complexo Hospitalario Universitario de Ferrol
Centro de atención
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (5)
2024
-
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision
The British journal of surgery, Vol. 111, Núm. 5
2021
-
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study
Microbiology Spectrum, Vol. 9, Núm. 3
-
Impact of the COVID-19 pandemic on tuberculosis management in Spain
International Journal of Infectious Diseases, Vol. 108, pp. 300-305
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2014
-
Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity
Endocrine, Vol. 47, Núm. 3, pp. 793-805